1

Cone beam CT for liver cancer during TACE

News Discuss 
Dr. Jeff Geschwind is a global leader in liver cancer treatment, serving as Director of Oncology at USA Clinics Group and Medical Director at NAMSA. With pioneering work in tumor metabolism and image-guided therapy, he has shaped modern Interventional Oncology through groundbreaking research, clinical innovation, and advanced cancer therapeutics. https://jeffgeschwind.com/honors/

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story